Interazioni tra farmaci
Blinatumomab + Ethosuximide
Gravità: Moderata
Blinatumomab and Ethosuximide: moderate interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Blinatumomab causes transient cytokine release that can suppress CYP enzymes, potentially raising levels of ethosuximide. The risk is greatest during the first days of treatment cycles.
Cosa significa questa interazione in parole semplici
Blinatumomab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Blinatumomab belongs to Oncology; Ethosuximide belongs to Central Nervous System.
Perché avviene
Cytokine-mediated transient suppression of CYP450 enzymes reduces ethosuximide metabolism.
Cosa fare
Monitor for ethosuximide toxicity such as drowsiness, nausea and ataxia during the first days of each cycle, and check drug levels if symptomatic.
Cosa chiedere al farmacista
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Blinatumomab e Ethosuximide, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Ethosuximide
- Benzhydrocodone / acetaminophen + Ethosuximide Maggiore
- Buprenorphine long-acting + Ethosuximide Maggiore
- Buprenorphine subdermal implant + Ethosuximide Maggiore
- Buprenorphine transdermal + Ethosuximide Maggiore
- Calcium / magnesium / potassium / sodium oxybates + Ethosuximide Maggiore
- Ethosuximide + Fentanyl intranasal Maggiore
Altre interazioni di Blinatumomab
- Blinatumomab + Carbamazepine Moderata
- Blinatumomab + Cyclosporin Moderata
- Blinatumomab + Phenytoin Moderata
- Blinatumomab + Quinidine Moderata
- Blinatumomab + Quinine Moderata
- Blinatumomab + Siponimod Moderata
Domande frequenti
Can I take Blinatumomab with Ethosuximide?
MediHelp rates the interaction as moderate. Blinatumomab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab causes transient cytokine release that can suppress CYP enzymes, potentially raising levels of ethosuximide. The risk is greatest during the first days of treatment cycles.
How serious is the interaction between Blinatumomab and Ethosuximide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ethosuximide toxicity such as drowsiness, nausea and ataxia during the first days of each cycle, and check drug levels if symptomatic.
What other medicines interact with Ethosuximide?
MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
